London (CNN Business) – The European Union is challenging the manufacturers of AstraZeneca and Pfizer caravans during the talks in which the podium will recover from the recovery of the pandemic. The employees including amenazan to take legal action and impress export controls on the doses produced in the European bloc through which the euro increases.
AstraZeneca will not be able to extract such doses from its vacancy as a promissory note, according to European Union officials, which will jeopardize Gobiernos’ implementation plans. The news broke that Pfizer was dying, last week, that he had reduced his dose of his vaccine by that time.
The European Union’s Health Commissioner, Stella Kyriakides, expressed her displeasure at the talks with AstraZeneca and said they were ongoing. Dijo that the pharmaceutical “has the intention to consider considerably less dosage in the weekly and approved proxies.”
The president of the European Commission, Ursula von der Leyen, praised the pharmaceutical companies on March, saying that the block was “serious”.
«Europe invests millions of millions to help unleash the first vacancies against the covid-19 of the world, to create a common good worldwide. And now the companies need to complete. Deben complies with its obligations “, said during a virtual meeting of the World Economic Forum.
The countries of the European Union that are taking vacancies to alleviate the sanitary crisis and reactivate their economies are now obliged to modify their plans. The Deputy Minister of Health of Italy, Pierpaolo Sileri, said he was a member of the Rai 1 television channel, as the 80-year-olds had been evacuated four weeks later as planned as a result of the retreats. The country is planning to take legal action against drug manufacturers.
“For the eighth year we will have up to 45 million Italians, but we will not create these companies,” said Sileri. “I would like to see the vacancies”.
Untreated retreats with AstraZeneca and Pfizer vehicles
The European Union has issued a 300 million dose of the AstraZeneca vaccine, which can be approved as soon as this week, with the option to purchase an additional 100 million.
The company says production has been hampered by a manufacturing problem.
“If there is not yet a return program for the initiation of the vacancies in our case in case we receive the approval in Europe, the initial volumes will be lower than the original original debt to the reduction in yields at a manufacturing site. of our European Summit Office », says AstraZeneca in a statement. “We will be taking tens of thousands of doses in February and March to the European Union, while continuing to increase production volumes.”
The notice has been tampered with in the block, just as it is being appraised to evaluate the impact of the announcements made by Pfizer. The company stands on the 15th of January which will reduce the number of plans for the past week, while increasing its manufacturing facilities in Puurs, Belgium.
The pharmaceutical company says that a powder completes the goals of the first trimester and, as a result of the changes in its plant in Belgium, the powder produces 2,000 million doses for fines of 2021. So there are more than 1,300 million that originally hold. estimated.
Pfizer has announced that it will launch its original program of entries for the European Union this week.
European governors are demanding answers, saying that the success of their evacuation efforts depends on the private sector.
“For a lady, only we can look forward to the result of science, and for another lady, they have a monopoly and we are totally dependent”, said the Minister of Health of Belgium, Frank Vandenbroucke. “You can have production problems, but there are times and announcements that you can hardly organize the campaign”.
Kyriakides is talking about the moon that the block now requires “total transparency in relation to the export of cars” of the European Union.
“In the future, all companies that produce vehicles against covid-19 in the European Union tend to notify each other that they are exporting vehicles and third countries. Humanitarian entities, by supuesto, are not affected by this », said on Twitter.
How bad is it?
The expert experts in the field of equestrianism are much more concerned about the AstraZeneca news that Pfizer gave the compromise of this ultimate company to increase production immediately. The AstraZeneca car, designed by the University of Oxford, is also much easier to distribute because it can maintain higher temperatures than the Pfizer alternative.
A one-week retrospective on “there is no big problem”, said Burak Kazaz, professor of Cedar Cadence Management at the University of Syracuse. «[Aunque] certainly meaning that a significant retreat [la pérdida de] vidas ».
The problem of AstraZeneca’s problems, which are more serious, will be clarified in the following weeks.
The company’s retrievals are a signal that todavia has problems in the summit’s cadence that must be resolved by increasing distribution, says Prashant Yadav, expert in the center’s medical cadence cadre and main member for the Development
“We’re going to have more of these high-stakes games than ever before,” said Yadav.
Given the difficult intentions of doing so — and the concentration of production in one of these manufacturing sites — the public must hope that the monthly manufacturing capacity fluctuates at the moment, aggregate.
Richard Wilding, Professor of Estrategia de la Cadena de Suministro, en la Universidad de Cranfield, Inglaterra, señaló que hay al menos 50 elements necessary to administer the evacuation sites, from toilets with alcohol and jeringas hasta staff for personal protection. The cadence of the summit of these articles also works without problems.
Basically, retrasos have no problem with Europe.
“The price he pays for lands in development that we do not have access to, because his entrees can retrieve more adelante”, says Yadav.
– James Frater, Chris Liakos, Amanda Sealy and Stephanie Halasz contribute to this note.